<DOC>
	<DOCNO>NCT00152945</DOCNO>
	<brief_summary>Lipoproteins large complex molecule transport lipid ( primarily triglycerides cholesterol ) blood . The intestine traditionally view 'passive ' organ respect lipoprotein production , intestinal lipoprotein production rate respond mainly fat ingestion absorption . The investigator recently demonstrate animal model overproduction intestinal lipoprotein fast fed state . The investigator also recently demonstrate elevation plasma free fatty acid ( FFAs ) stimulate intestinal lipoprotein hamster . It know whether intestinal lipoprotein production acutely stimulate elevation plasma FFAs human . Hypothesis : Intestinal lipoprotein particle production human stimulate acute elevation plasma free fatty acid .</brief_summary>
	<brief_title>Determining Responsiveness Intestinal Lipoprotein Production Elevation Plasma Free Fatty Acids</brief_title>
	<detailed_description>This study propose use publish stable isotope method study kinetics apoB48 apoB100 constant fed state healthy subject . These study perform 10 healthy , lean men woman age 18 65 year age . Each subject serve his/her control undergo 3 separate lipoprotein turnover study , random order , 4 6 week apart . Since infusion intralipid ( synthetic triglyceride emulsion provide source fatty acid ) heparin ( activate lipoprotein lipase ) raise FFAs glycerol , two control study perform , one saline one glycerol infusion . ApoB48-containing lipoprotein particle production determine outline study fast state , response follow intervention : 1 . Intralipid ( 20 % solution @ 40 ml/hr ) heparin ( 250 u/hr ) infusion achieve ~2-fold elevation plasma FFAs ( previously show ) , start 90 minute prior continue throughout lipoprotein turnover experiment , 2 . Saline infusion control study , 3 . Glycerol control study glycerol infuse rate 2.25 g/hr simulate infusion glycerol contain Intralipid . Stable isotope infusion protocol . Following 14-h overnight fast , IV insert superficial vein forearm , one infusion one sampling . At 7 , fast blood sample drawn subject begin ingest first 15 identical small hourly meal , equivalent 1/15th daily food intake . This achieve give patient drink BOOST ( Mead Johnson Nutritionals , Ottawa , On ) , use Harris Benedict Equation ( HBE ) determine number total energy requirement . This base height , weight , age activity factor . The subject nothing else eat end study . At time IV infusion either heparin plus intralipid saline glycerol indicate start . At 10 ( 3 hour start ingestion hourly feed ) , primed-constant infusion deuterium-labeled leucine ( [ D3 ] L-leucine 98 % , Cambridge Isotope Laboratories , MA ) start , previously describe ( 0.6 mg/kg initial injection 0.6 mg/kg/hr thereafter ) . In addition , IV bolus d5-glycerol ( 100 mmol/kg ) administer . These standard technique use assessment lipoprotein metabolism human . Leucine , amino acid glycerol , intermediary metabolite , use cell body build block protein , fat energy . The form leucine administer deuterated leucine ( chemical formula L- [ 5,5,5-2H3 ] ) form glycerol d5-glycerol , enrich naturally occur isotope ( chemical variant ) hydrogen ( 2H ) . Deuterated leucine glycerol stable isotope occur naturally environment body , health/safety issue regard infusion amount deuterated leucine glycerol indicate . The solution prepare use sterile technique monitor contamination prior administration . Blood sample collect prior follow time point administration stable isotope : 1hr , 2hr , 3hr , 5hr , 7hr , 9hr , 10hr , 11hr 12hr . A total 340 ml blood drawn .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>1 . Nondiabetic men woman age 1865 year old 2 . Written inform consent obtain 3 . Body mass index ( BMI ) &lt; 27 kg/m2 4 . Fasting triglyceride &lt; 2.5 mmol/l 5 . Waist circumference &lt; 90 cm 6 . Fasting blood glucose &lt; 6 mmol/l 7 . Haemoglobin 130 g/L . 1 . Patient history hepatitis/hepatic disease active within previous 2 year . 2 . Any significant active ( past 12 month ) disease gastrointestinal , pulmonary , neurological , renal ( creatinine [ Cr ] &gt; 1.5 mg/dL ) genitourinary , hematological system ; severe uncontrolled treat untreated hypertension ( sit diastolic blood pressure [ BP ] &gt; 100 systolic &gt; 180 ) ; proliferative retinopathy . 3 . Fasting blood glucose &gt; 6 mmol/l know diabetes . 4 . Any history myocardial infarction ( MI ) clinically significant , active , cardiovascular history include history arrhythmias conduction delay electrocardiogram ( ECG ) , unstable angina , decompensated heart failure . 5 . Any laboratory value : AST &gt; 2x upper limit normal ( ULN ) ; ALT &gt; 2x ULN ; thyroidstimulating hormone ( TSH ) &gt; 6 mU/l . 6 . Known suspected allergy medication history multiple and/or severe allergy drug food history severe anaphylactic reaction . 7 . Current addiction alcohol substance abuse determine investigator . 8 . Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation 9 . Any lipid lowering hypoglycemic agent 10 . Will donate blood three month start three month complete study . 11 . Thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>intestinal lipoprotein</keyword>
	<keyword>low density lipoprotein</keyword>
	<keyword>free fatty acid</keyword>
	<keyword>Apo B48 Apo B100</keyword>
	<keyword>triglyceride</keyword>
	<keyword>Intestinal lipoprotein production</keyword>
</DOC>